Evidence map›Paper›PMID 29459481›Full record

ArticleJournal of lipid research2018

Catalytic activities of mammalian epoxide hydrolases with

Haruto Yamanashi, William E Boeglin, Christophe Morisseau, Robert W Davis, Gary A Sulikowski, Bruce D Hammock, Alan R Brash

Open access · hybridAbstract read
In one paragraph

Article in Journal of lipid research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
3.0field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 34 citations in OpenAlex.

  1. Discovery of Dihydroxy-Ketone-Type Protein-Bound Ceramides as the Dominant Type in Human Stratum Corneum.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2026
    Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. The Multifaceted Role of Epoxide Hydrolases in Human Health and Disease.International journal of molecular sciences · 2020
    Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Haruto YamanashiDepartments of Pharmacology Vanderbilt University School of Medicine, Nashville, TN 37232; Department of Dermatology and Allergology, Juntendo University Graduate School of Medicine, Bunkyo-ku, Tokyo 113-8421, Japan.
William E BoeglinDepartments of Pharmacology Vanderbilt University School of Medicine, Nashville, TN 37232.
Christophe MorisseauDepartment of Entomology and Nematology and Comprehensive Cancer Research Center, University of California, Davis, Davis, CA 95616.
Robert W DavisChemistry and the Vanderbilt Institute of Chemical Biology, Vanderbilt University School of Medicine, Nashville, TN 37232.
Gary A SulikowskiChemistry and the Vanderbilt Institute of Chemical Biology, Vanderbilt University School of Medicine, Nashville, TN 37232.
Bruce D HammockDepartment of Entomology and Nematology and Comprehensive Cancer Research Center, University of California, Davis, Davis, CA 95616.
Alan R BrashDepartments of Pharmacology Vanderbilt University School of Medicine, Nashville, TN 37232. Electronic address: alan.brash@vanderbilt.edu.
Vanderbilt University · USCancer Research Center · USUniversity of California, Davis · US

Funding

Tumor Immunology and Microenvironment Research ProgramP30CA068485 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI MATTHEW J TYSKA · 1995 to 2026
$172.8M
Workshop on Environmental Technology Transfer and EntrepreneurshipP42ES004699 · NIEHS · UNIVERSITY OF CALIFORNIA DAVIS · PI HAMMOCK, BRUCE D · 1987 to 2021
$50.1M
HYDROLYTIC ENZYMES IN THE METABOLISM OF TOXINSR01ES002710 · NIEHS · UNIVERSITY OF CALIFORNIA DAVIS · PI HAMMOCK, BRUCE D · 1985 to 2018
$4.0M
Linking Lipoxygenases with Essential Fatty Acids and Epidermal Barrier FormationR01AR051968 · NIAMS · VANDERBILT UNIVERSITY · PI BRASH, ALAN R. · 2005 to 2016
$3.0M
Chemistry and Biology of Novel Arachidonic Acid MetabolitesR01GM115722 · NIGMS · VANDERBILT UNIVERSITY · PI SULIKOWSKI, GARY ALLEN · 2015 to 2018
$1.2M
NCI NIH HHS P30 CA068485NIAMS NIH HHS R01 AR051968NIEHS NIH HHS P42 ES004699NIEHS NIH HHS R01 ES002710NIGMS NIH HHS R01 GM115722
6 · The paper itself

Abstract

Lipoxygenase (LOX)-catalyzed oxidation of the essential fatty acid, linoleate, represents a vital step in construction of the mammalian epidermal permeability barrier. Analysis of epidermal lipids indicates that linoleate is converted to a trihydroxy derivative by hydrolysis of an epoxy-hydroxy precursor. We evaluated different epoxide hydrolase (EH) enzymes in the hydrolysis of skin-relevant fatty acid epoxides and compared the products to those of acid-catalyzed hydrolysis. In the absence of enzyme, exposure to pH 5 or pH 6 at 37°C for 30 min hydrolyzed fatty acid allylic epoxyalcohols to four trihydroxy products. By contrast, human soluble EH [sEH (EPHX2)] and human or murine epoxide hydrolase-3 [EH3 (EPHX3)] hydrolyzed

Indexed as

AnimalsBiocatalysisCell LineEpoxide HydrolasesEpoxy CompoundsFatty AcidsHumansHydrogen-Ion ConcentrationMiceSkinStereoisomerismEpoxide HydrolasesEpoxy CompoundsFatty Acids14,15-epoxyeicosatrienoic acidepidermisichthyosislinoleic acidlipoxygenasetrihydroxy-linoleate

Identifiers

PMID29459481
PMCPMC5880498
OpenAlexW2788737826

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.